CAPITAL B (ALCPB.PA) Fundamental Analysis & Valuation

EPA:ALCPB • FR0011053636

Current stock price

0.612 EUR
-0.01 (-0.81%)
Last:

This ALCPB.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ALCPB.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALCPB was profitable.
  • In the past year ALCPB had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: ALCPB reported negative net income in multiple years.
  • ALCPB had a positive operating cash flow in 4 of the past 5 years.
ALCPB.PA Yearly Net Income VS EBIT VS OCF VS FCFALCPB.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

  • ALCPB has a Return On Assets (4.00%) which is in line with its industry peers.
  • ALCPB has a Return On Equity (11.33%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 4%
ROE 11.33%
ROIC N/A
ROA(3y)-22.55%
ROA(5y)-12.7%
ROE(3y)-96.83%
ROE(5y)-38.45%
ROIC(3y)N/A
ROIC(5y)N/A
ALCPB.PA Yearly ROA, ROE, ROICALCPB.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

1.3 Margins

  • With a decent Profit Margin value of 9.81%, ALCPB is doing good in the industry, outperforming 61.82% of the companies in the same industry.
  • ALCPB's Profit Margin has been stable in the last couple of years.
  • Looking at the Gross Margin, with a value of 60.18%, ALCPB is doing worse than 60.91% of the companies in the same industry.
  • ALCPB's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 9.81%
GM 60.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y1.01%
GM growth 3Y3.05%
GM growth 5Y5.75%
ALCPB.PA Yearly Profit, Operating, Gross MarginsALCPB.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

6

2. ALCPB.PA Health Analysis

2.1 Basic Checks

  • ALCPB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ALCPB has more shares outstanding
  • The number of shares outstanding for ALCPB has been increased compared to 5 years ago.
  • Compared to 1 year ago, ALCPB has an improved debt to assets ratio.
ALCPB.PA Yearly Shares OutstandingALCPB.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ALCPB.PA Yearly Total Debt VS Total AssetsALCPB.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • An Altman-Z score of 3.15 indicates that ALCPB is not in any danger for bankruptcy at the moment.
  • ALCPB has a better Altman-Z score (3.15) than 60.91% of its industry peers.
  • ALCPB has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of ALCPB (0.29) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Altman-Z 3.15
ROIC/WACCN/A
WACC8.29%
ALCPB.PA Yearly LT Debt VS Equity VS FCFALCPB.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

  • A Current Ratio of 3.42 indicates that ALCPB has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 3.42, ALCPB belongs to the best of the industry, outperforming 87.27% of the companies in the same industry.
  • ALCPB has a Quick Ratio of 3.42. This indicates that ALCPB is financially healthy and has no problem in meeting its short term obligations.
  • ALCPB's Quick ratio of 3.42 is amongst the best of the industry. ALCPB outperforms 87.27% of its industry peers.
Industry RankSector Rank
Current Ratio 3.42
Quick Ratio 3.42
ALCPB.PA Yearly Current Assets VS Current LiabilitesALCPB.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

5

3. ALCPB.PA Growth Analysis

3.1 Past

  • ALCPB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 106.90%, which is quite impressive.
  • The Earnings Per Share has been growing slightly by 2.82% on average over the past years.
  • Looking at the last year, ALCPB shows a very negative growth in Revenue. The Revenue has decreased by -32.07% in the last year.
  • The Revenue has been growing by 43.44% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)106.9%
EPS 3YN/A
EPS 5Y2.82%
EPS Q2Q%100%
Revenue 1Y (TTM)-32.07%
Revenue growth 3Y-4.3%
Revenue growth 5Y43.44%
Sales Q2Q%-33.18%

3.2 Future

  • The Earnings Per Share is expected to grow by 25.99% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, ALCPB will show a very negative growth in Revenue. The Revenue will decrease by -22.16% on average per year.
EPS Next Y100%
EPS Next 2Y41.42%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue Next Year-64%
Revenue Next 2Y-35.51%
Revenue Next 3Y-22.16%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALCPB.PA Yearly Revenue VS EstimatesALCPB.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
ALCPB.PA Yearly EPS VS EstimatesALCPB.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 -0.02 -0.04 -0.06 -0.08 -0.1

2

4. ALCPB.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 30.60 indicates a quite expensive valuation of ALCPB.
  • The rest of the industry has a similar Price/Earnings ratio as ALCPB.
  • When comparing the Price/Earnings ratio of ALCPB to the average of the S&P500 Index (26.21), we can say ALCPB is valued inline with the index average.
Industry RankSector Rank
PE 30.6
Fwd PE N/A
ALCPB.PA Price Earnings VS Forward Price EarningsALCPB.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALCPB.PA Per share dataALCPB.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 0.06

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ALCPB's earnings are expected to grow with 25.99% in the coming years.
PEG (NY)0.31
PEG (5Y)10.83
EPS Next 2Y41.42%
EPS Next 3Y25.99%

0

5. ALCPB.PA Dividend Analysis

5.1 Amount

  • No dividends for ALCPB!.
Industry RankSector Rank
Dividend Yield 0%

ALCPB.PA Fundamentals: All Metrics, Ratios and Statistics

CAPITAL B

EPA:ALCPB (4/2/2026, 7:00:00 PM)

0.612

-0.01 (-0.81%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners1.92%
Inst Owner ChangeN/A
Ins Owners7.46%
Ins Owner ChangeN/A
Market Cap140.18M
Revenue(TTM)13.86M
Net Income(TTM)1.36M
Analysts84.44
Price Target1.73 (182.68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 30.6
Fwd PE N/A
P/S 10.11
P/FCF N/A
P/OCF 737.81
P/B 11.68
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.02
EY3.27%
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0
OCFY0.14%
SpS0.06
BVpS0.05
TBVpS-0.04
PEG (NY)0.31
PEG (5Y)10.83
Graham Number0.15
Profitability
Industry RankSector Rank
ROA 4%
ROE 11.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 9.81%
GM 60.18%
FCFM N/A
ROA(3y)-22.55%
ROA(5y)-12.7%
ROE(3y)-96.83%
ROE(5y)-38.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y1.01%
GM growth 3Y3.05%
GM growth 5Y5.75%
F-Score5
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 126.79%
Cap/Sales 15.36%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.42
Quick Ratio 3.42
Altman-Z 3.15
F-Score5
WACC8.29%
ROIC/WACCN/A
Cap/Depr(3y)108.31%
Cap/Depr(5y)N/A
Cap/Sales(3y)15.27%
Cap/Sales(5y)15.02%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)106.9%
EPS 3YN/A
EPS 5Y2.82%
EPS Q2Q%100%
EPS Next Y100%
EPS Next 2Y41.42%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue 1Y (TTM)-32.07%
Revenue growth 3Y-4.3%
Revenue growth 5Y43.44%
Sales Q2Q%-33.18%
Revenue Next Year-64%
Revenue Next 2Y-35.51%
Revenue Next 3Y-22.16%
Revenue Next 5YN/A
EBIT growth 1Y81.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-2136.47%
EBIT Next 3Y-117.27%
EBIT Next 5YN/A
FCF growth 1Y-466.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-92.78%
OCF growth 3Y-56.24%
OCF growth 5Y35.24%

CAPITAL B / ALCPB.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CAPITAL B (ALCPB.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALCPB.PA.


What is the valuation status of CAPITAL B (ALCPB.PA) stock?

ChartMill assigns a valuation rating of 2 / 10 to CAPITAL B (ALCPB.PA). This can be considered as Overvalued.


What is the profitability of ALCPB stock?

CAPITAL B (ALCPB.PA) has a profitability rating of 3 / 10.


What is the valuation of CAPITAL B based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CAPITAL B (ALCPB.PA) is 30.6 and the Price/Book (PB) ratio is 11.68.


What is the financial health of CAPITAL B (ALCPB.PA) stock?

The financial health rating of CAPITAL B (ALCPB.PA) is 6 / 10.